HSP90AA1 and cervical squamous cell carcinoma: According to survival analysis, CESC patients with high expression of HSP90AA1 had considerably worse RFS (recurrence-free survival) than patients with low expression (Fig. 7B), indicating a strong negative correlation between high expression of HSP90AA1 and a bad prognosis in CESC patients.